MarketWatch: Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma Medical Xpress on MSN: A new glioblastoma target: Blocking CD47 protein's tumor-driving role may slow growth Australian researchers have uncovered a critical mechanism driving the growth and spread of glioblastoma—one of the most aggressive and lethal forms of brain cancer—potentially paving the way for more ... A new glioblastoma target: Blocking CD47 protein's tumor-driving role may slow growth The diagnosis was glioblastoma, one of the most aggressive forms of brain cancer. Standard treatment typically involves three steps: surgery to remove as much of the tumor as possible, followed by ...
Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found that certain brain cells—once believed to only support healthy nerves—can ... Boston.com on MSN: His brother passed away from glioblastoma. He’s running Boston for cancer research "The grant will support researchers at Massachusetts General Hospital who study how glioblastoma evolves." The post His brother passed away from glioblastoma.
glioblastoma, He’s running Boston for cancer research ... His brother passed away from glioblastoma. He’s running Boston for cancer research Medical Xpress: Scientists discover way to slow or block recurrence of glioblastoma Phys.org on MSN: Dual-drug nanotherapy crosses blood–brain barrier, improving survival in preclinical glioblastoma models NBC News: Michael Bolton reveals glioblastoma diagnosis: ‘You find out what you’re made of’ Michael Bolton reveals glioblastoma diagnosis: ‘You find out what you’re made of’
